Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
Total Assignments:
6
|
Patent #:
|
|
Issue Dt:
|
02/05/2019
|
Application #:
|
15360332
|
Filing Dt:
|
11/23/2016
|
Publication #:
|
|
Pub Dt:
|
06/01/2017
| | | | |
Inventor:
|
Maurice Raymond Verschoyle Finlay
|
Title:
|
bis-Pyridazine Compounds and Their Use in Treating Cancer
|
|
Assignment:
1
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
2 KINGDOM STREET |
LONDON, ENGLAND W2 6BD |
|
|
|
MEDIMMUNE, INC. |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
2
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
SE-151 85 |
SODERTALJE, SWEDEN |
|
|
|
MEDIMMUNE, INC. |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
3
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
1 FRANCIS CRICK AVENUE |
CAMBRIDGE BIOMEDICAL CAMPUS |
CAMBRIDGE, UNITED KINGDOM CB2 0AA |
|
|
|
ASTRAZENECA PHARMACEUTICALS |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
4
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
SE-151 85 |
SODERTALJE, SWEDEN |
|
|
|
ASTRAZENECA PHARMACEUTICALS |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
5
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
SE-151 85 |
SODERTALJE, SWEDEN |
|
|
ANGEL BUILDING |
407 ST. JOHN STREET |
LONDON, UNITED KINGDOM EC1V 4AD |
|
|
|
ASTRAZENECA PHARMACEUTICALS |
ONE MEDIMMUNE WAY |
GAITHERSBURG, MD 20878 |
|
|
Assignment:
6
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
ANGEL BUILDING, 407 ST. JOHN STREET |
LONDON, ENGLAND EC1V4AD |
|
|
|
MCCARTER & ENGLISH, LLP |
265 FRANKLIN STREET |
BOSTON, MA 02110 |
|
|
Search Results as of:
06/19/2024 09:49 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|